The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches. Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. N. Engl. J. Med. 378 , 169–180 (2018). This research was supported in part by the Intramural Research Program of the US National Institutes of Health (NIH). The contributions of the NIH authors are considered works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services. Division of Neurology, Department of Medicine, St.
The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches.
Access to this article via Institution of Civil Engineers Library is not available.
Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. N. Engl. J. Med. 378 , 169–180 (2018).
This research was supported in part by the Intramural Research Program of the US National Institutes of Health (NIH). The contributions of the NIH authors are considered works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services.
Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK
The Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, London, UK
Neurology Unit, Neurorehabilitation Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
Neurophysiology Service, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Neurology, University Hospital and University of Basel, Basel, Switzerland
Research Center for Clinical Neuroimmunology, University Hospital, University of Basel, Basel, Switzerland
Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital, University of Basel, Basel, Switzerland
Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea